BB&T Securities’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $684K | Buy |
6,993
+173
| +3% | +$16.9K | 0.01% | 963 |
|
|
2019
Q2 | $893K | Buy |
6,820
+561
| +9% | +$73.5K | 0.01% | 858 |
|
|
2019
Q1 | $846K | Buy |
6,259
+2,313
| +59% | +$313K | 0.01% | 867 |
|
|
2018
Q4 | $384K | Sell |
3,946
-684
| -15% | -$66.6K | ﹤0.01% | 1077 |
|
|
2018
Q3 | $643K | Buy |
4,630
+587
| +15% | +$81.5K | 0.01% | 975 |
|
|
2018
Q2 | $501K | Buy |
4,043
+404
| +11% | +$50.1K | 0.01% | 1075 |
|
|
2018
Q1 | $405K | Buy |
3,639
+248
| +7% | +$27.6K | ﹤0.01% | 1098 |
|
|
2017
Q4 | $405K | Buy |
3,391
+10
| +0.3% | +$1.19K | 0.01% | 1062 |
|
|
2017
Q3 | $474K | Buy |
3,381
+227
| +7% | +$31.8K | 0.01% | 978 |
|
|
2017
Q2 | $383K | Sell |
3,154
-4,279
| -58% | -$520K | 0.01% | 1052 |
|
|
2017
Q1 | $901K | Sell |
7,433
-4,501
| -38% | -$546K | 0.01% | 683 |
|
|
2016
Q4 | $1.46M | Hold |
11,934
| – | – | 0.02% | 517 |
|
|
2016
Q3 | $1.46M | Buy |
11,934
+3,402
| +40% | +$417K | 0.02% | 512 |
|
|
2016
Q2 | $996K | Buy |
8,532
+2,278
| +36% | +$266K | 0.02% | 598 |
|
|
2016
Q1 | $870K | Buy |
6,254
+438
| +8% | +$60.9K | 0.01% | 611 |
|
|
2015
Q4 | $1.11M | Buy |
5,816
+1,060
| +22% | +$202K | 0.02% | 500 |
|
|
2015
Q3 | $743K | Buy |
4,756
+690
| +17% | +$108K | 0.02% | 584 |
|
|
2015
Q2 | $735K | Buy |
4,066
+2,351
| +137% | +$425K | 0.02% | 613 |
|
|
2015
Q1 | $2.97M | Buy |
1,715
+311
| +22% | +$539K | 0.01% | 882 |
|
|
2014
Q4 | $2.6M | Buy |
+1,404
| New | +$2.6M | 0.01% | 931 |
|
|
2014
Q1 | – | Sell |
-1,609
| Closed | -$2.14M | – | 967 |
|
|
2013
Q4 | $2.14M | Buy |
+1,609
| New | +$2.14M | 0.01% | 816 |
|